FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788124846> ?p ?o ?g. }

• W2788124846 endingPage "1043" @default.
• W2788124846 startingPage "1034" @default.
• W2788124846 abstract "BACKGROUND:Histone acetylation and DNA methylation are important mammalian epigenetic modifications that participate in the regulation of gene expression. Because dysregulation of histone deacetylase and DNA methyltransferases are hallmarks of malignancy, they have become promising therapeutic targets. In this study, we explored the anti-tumor activity of valproic acid (VPA), a histone deacetylase inhibitor (HDACi) and 5-Aza-2’-deoxycytidine (5-Aza), an inhibitor of DNA methyltransferases, on renal cell carcinoma (RCC) cell lines 786-O and 769-P. MATERIAL AND METHODS:The cell proliferation was detected by xCELLigence RTCA DP Instrument, viability by CCK8 assay, cell apoptosis and cell cycle by flow cytometry, and cell migration by wound healing assay, Transwell assay and xCELLigence RTCA DP Instrument. RESULTS:We discovered that VPA and 5-Aza could individually induce decreased viability and have an inhibitory effect on the proliferation of 786-O and 769-P cells. This anti-growth effect was more pronounced when the cells were treated with both VPA and 5-Aza. The combination of VPA and 5-Aza also elicited more apoptosis and produced more cell cycle arrest in the G1 phase for both cell lines. On the other hand, treatment of RCC cells with VPA, 5-Aza, or a combination of both resulted in slow wound healing and impaired migration. CONCLUSIONS:These findings clearly demonstrated that VPA combined with 5-Aza could significantly increase anti-RCC effects by inhibiting cellular proliferation, inducing apoptosis, promoting cell cycle arrest and prohibiting the migration of human RCC cells." @default.
• W2788124846 created "2018-03-06" @default.
• W2788124846 creator A5025300008 @default.
• W2788124846 creator A5047435502 @default.
• W2788124846 creator A5050491740 @default.
• W2788124846 creator A5056656260 @default.
• W2788124846 creator A5057701729 @default.
• W2788124846 creator A5061619739 @default.
• W2788124846 creator A5069582554 @default.
• W2788124846 creator A5074217726 @default.
• W2788124846 creator A5078797115 @default.
• W2788124846 creator A5085142676 @default.
• W2788124846 date "2018-02-19" @default.
• W2788124846 modified "2023-10-18" @default.
• W2788124846 title "Combined Treatment with Valproic Acid and 5-Aza-2’-Deoxycytidine Synergistically Inhibits Human Clear Cell Renal Cell Carcinoma Growth and Migration" @default.
• W2788124846 cites W1504303645 @default.
• W2788124846 cites W1551750271 @default.
• W2788124846 cites W1968848049 @default.
• W2788124846 cites W1972311665 @default.
• W2788124846 cites W1974938521 @default.
• W2788124846 cites W1976043651 @default.
• W2788124846 cites W1984025642 @default.
• W2788124846 cites W1988220701 @default.
• W2788124846 cites W2004078197 @default.
• W2788124846 cites W2007355431 @default.
• W2788124846 cites W2014293873 @default.
• W2788124846 cites W2022165152 @default.
• W2788124846 cites W2028098384 @default.
• W2788124846 cites W2043103956 @default.
• W2788124846 cites W2049767205 @default.
• W2788124846 cites W2057366527 @default.
• W2788124846 cites W2059024085 @default.
• W2788124846 cites W2060467730 @default.
• W2788124846 cites W2070471476 @default.
• W2788124846 cites W2071934663 @default.
• W2788124846 cites W2082331198 @default.
• W2788124846 cites W2097863827 @default.
• W2788124846 cites W2101376833 @default.
• W2788124846 cites W2113726374 @default.
• W2788124846 cites W2114843024 @default.
• W2788124846 cites W2116949558 @default.
• W2788124846 cites W2117691193 @default.
• W2788124846 cites W2129604622 @default.
• W2788124846 cites W2141410747 @default.
• W2788124846 cites W2158106117 @default.
• W2788124846 cites W2159687068 @default.
• W2788124846 cites W2169961966 @default.
• W2788124846 cites W2219978888 @default.
• W2788124846 cites W2287273954 @default.
• W2788124846 cites W2308485224 @default.
• W2788124846 cites W2315916150 @default.
• W2788124846 cites W2400136780 @default.
• W2788124846 cites W2464943538 @default.
• W2788124846 doi "https://doi.org/10.12659/msm.906020" @default.
• W2788124846 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5827631" @default.
• W2788124846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29457966" @default.
• W2788124846 hasPublicationYear "2018" @default.
• W2788124846 type Work @default.
• W2788124846 sameAs 2788124846 @default.
• W2788124846 citedByCount "12" @default.
• W2788124846 countsByYear W27881248462019 @default.
• W2788124846 countsByYear W27881248462020 @default.
• W2788124846 countsByYear W27881248462021 @default.
• W2788124846 countsByYear W27881248462022 @default.
• W2788124846 countsByYear W27881248462023 @default.
• W2788124846 crossrefType "journal-article" @default.
• W2788124846 hasAuthorship W2788124846A5025300008 @default.
• W2788124846 hasAuthorship W2788124846A5047435502 @default.
• W2788124846 hasAuthorship W2788124846A5050491740 @default.
• W2788124846 hasAuthorship W2788124846A5056656260 @default.
• W2788124846 hasAuthorship W2788124846A5057701729 @default.
• W2788124846 hasAuthorship W2788124846A5061619739 @default.
• W2788124846 hasAuthorship W2788124846A5069582554 @default.
• W2788124846 hasAuthorship W2788124846A5074217726 @default.
• W2788124846 hasAuthorship W2788124846A5078797115 @default.
• W2788124846 hasAuthorship W2788124846A5085142676 @default.
• W2788124846 hasBestOaLocation W27881248462 @default.
• W2788124846 hasConcept C104317684 @default.
• W2788124846 hasConcept C105696609 @default.
• W2788124846 hasConcept C119157956 @default.
• W2788124846 hasConcept C137738243 @default.
• W2788124846 hasConcept C1491633281 @default.
• W2788124846 hasConcept C150194340 @default.
• W2788124846 hasConcept C153911025 @default.
• W2788124846 hasConcept C185592680 @default.
• W2788124846 hasConcept C190283241 @default.
• W2788124846 hasConcept C190727270 @default.
• W2788124846 hasConcept C2776202225 @default.
• W2788124846 hasConcept C2778305200 @default.
• W2788124846 hasConcept C29537977 @default.
• W2788124846 hasConcept C33288867 @default.
• W2788124846 hasConcept C502942594 @default.
• W2788124846 hasConcept C53227056 @default.
• W2788124846 hasConcept C552990157 @default.
• W2788124846 hasConcept C55493867 @default.
• W2788124846 hasConcept C62112901 @default.
• W2788124846 hasConcept C64927066 @default.
• W2788124846 hasConcept C86803240 @default.

• next